Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: A phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
We do not accept private insurance, Medicare, or Medicaid, but our services are still less expensive than many co-pays
The Science Cagrilintide is a long-acting analogue of amylin, a hormone naturally released by the pancreas alongside insulin after meals
Avoid drawing diluent into a syringe that has already touched another vial without sterilization
It is also almost entirely preclinical
US$ 26.25
US$ 26.62
US$ 27.20
US$ 28.24
US$ 24.44
US$ 21.31
US$ 27.00
US$ 22.39
US$ 20.21
US$ 29.75
US$ 29.00
US$ 20.75
US$ 20.27
US$ 24.23
